HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells

Background: Neoadjuvant chemotherapy (NACT) is routinely used to treat patients with advanced gastric cancer (AGC). However, the identification of reliable markers to determine which AGC patients would benefit from NACT remains challenging. Methods: A systematic screening of plasma proteins between...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zijian Chen, Xiaocheng Tang, Weiyao Li, Tuoyang Li, Jintuan Huang, Yingming Jiang, Jun Qiu, Zhenze Huang, Rongchang Tan, Xiang Ji, Li Lv, Zuli Yang, Hao Chen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-08-01
Edice:	Translational Oncology
Témata:	HIST1H2BK Neoadjuvant Chemotherapy Gastric Cancer Plasma 5-Fluorouracil
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S193652332400144X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!